HEMOGLOBIN-INDUCED VIRULENCE IN STREPTOCOCCUSPNEUMONIAE

肺炎链球菌中血红蛋白诱导的毒力

基本信息

  • 批准号:
    10369595
  • 负责人:
  • 金额:
    $ 19.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-10 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

1 Project summary 2 3 Streptococcus pneumoniae (Spn) colonizes the human upper airways of most children forming biofilms. Due 4 to mechanisms still not understood, nasopharyngeal carriage leads to invasive pneumococcal disease (IPD) 5 that kills more than one million individuals every year worldwide. IPD is characterized by colonization of the 6 lungs with subsequent translocation to the pleural cavity, and bloodstream, to cause lethal bacteremia. Once 7 in circulation, Spn translocates to the meninges causing meningitis or invades cardiomyocytes forming 8 intracellular biofilms that lead to cardiac damage. Although pneumococcal vaccination has reduced the 9 burden of disease, vaccines only target a subset of strains and have little to no impact against pneumococcal 10 bacteremia and meningitis. Efforts made in the last few years by this proposal's PIs have resulted in the 11 groundbreaking discovery that hemoglobin (Hb), a molecule that is accessible to Spn during carriage in the 12 upper airways and colonization of lung and heart, triggers the formation of robust biofilms and translocation 13 of pneumococci through human lung cells. These observations strongly support a new scientific premise that 14 Hb signaling is key to Spn colonization and disease processes. Our overarching goal is to identify the proteins 15 by which hemoglobin (Hb) triggers Spn virulence leading to the pathophysiology of pneumococcal disease 16 and to begin to describe the mechanism of Hb signaling in Spn. Specific Aim 1 will use a reverse genetic 17 approach to identify the proteins required for Hb to transduce a signal leading to the formation of biofilms, 18 and invasion of lung cells and cardiomyocytes. Whether this signal acts along with, or it is separated from, an 19 increased pool of intracellular iron will also be investigated. Specific Aim 2 will implement an agnostic 20 strategy (Tn-seq) to determine additional surface proteins and the regulators necessary for Hb signaling and 21 test key candidates defective in Hb signaling in vivo using murine models for pneumococcal colonization and 22 disease. At completion, this work will identify new proteins key for the pathophysiology of IPD, new antigens 23 for pneumococcal vaccines, and new targets for inhibitors that interfere with the establishment and 24 progression of IPD. 25 26 27 28 29 30
1项目概要 2 3肺炎链球菌(Spn)定植于大多数儿童的上呼吸道形成生物膜。由于 4到机制仍不清楚,鼻咽携带导致侵袭性肺炎球菌病(IPD) 5,每年在全世界造成100多万人死亡。IPD的特点是殖民化的 6个肺,随后移位到胸膜腔和血流,引起致命的菌血症。一旦 7在循环中,Spn移位到脑膜引起脑膜炎或侵入心肌细胞形成 8种细胞内生物膜导致心脏损伤。尽管肺炎球菌疫苗接种减少了 9疾病负担,疫苗仅针对一部分菌株,对肺炎球菌几乎没有影响 10例菌血症和脑膜炎。在过去几年中,该提案的PI所做的努力导致了 11突破性的发现,血红蛋白(Hb),一种在运输过程中可以接触到Spn的分子, 12上呼吸道和肺和心脏的定殖,触发稳健的生物膜和易位的形成 13的肺炎球菌通过人类肺细胞。这些观察结果有力地支持了一个新的科学前提, 14 Hb信号传导是Spn定殖和疾病过程的关键。我们的首要目标是找出 血红蛋白(Hb)触发Spn毒力,导致肺炎球菌疾病的病理生理学 16并开始描述Spn中Hb信号传导的机制。具体目标1将使用反向遗传 17.鉴定Hb所需的蛋白质以抑制导致生物膜形成的信号, 18和肺细胞和心肌细胞的侵袭。无论该信号是沿着作用还是与之分离, 还将研究增加的细胞内铁库。具体目标2将实现一个不可知论者 20策略(Tn-seq)以确定额外的表面蛋白和Hb信号传导所必需的调节剂, 21使用肺炎球菌定植的鼠模型在体内测试Hb信号传导缺陷的关键候选物, 22疾病在完成后,这项工作将确定新的蛋白质的关键的病理生理学的IPD,新的抗原 23肺炎球菌疫苗,和新的目标抑制剂干扰建立和 24、IPD的发展 25 26 27 28 29 30

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic Acid.
使用次级胆汁酸代谢物脱氧胆酸预防性抑制肺炎链球菌的定植。
  • DOI:
    10.1128/iai.00463-21
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Vidal,JorgeE;Wier,MeaganN;AAngulo-Zamudio,Uriel;McDevitt,Erin;JopVidal,AnaG;Alibayov,Babek;Scasny,Anna;Wong,SandyM;Akerley,BrianJ;McDaniel,LarryS
  • 通讯作者:
    McDaniel,LarryS
Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance.
  • DOI:
    10.1128/mbio.03325-22
  • 发表时间:
    2023-02-28
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
  • 通讯作者:
Effect of pneumococcal conjugate vaccine availability on Streptococcus pneumoniae infections and genetic recombination in Zhejiang, China from 2009 to 2019.
  • DOI:
    10.1080/22221751.2022.2040921
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    13.2
  • 作者:
    Wu X;Zhao S;Jiang Y;Xiang X;Ge L;Chen Q;Wang Y;Vidal JE;Yu Y
  • 通讯作者:
    Yu Y
The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model.
群体感应通信系统在伪分层气道组织模型中调节肺炎球菌定植和侵袭性疾病。
  • DOI:
    10.1016/j.micres.2022.127297
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Kahlert,ChristianR;Nigg,Susanne;Onder,Lucas;Dijkman,Ronald;Diener,Liliane;Vidal,AnaGJop;Rodriguez,Regulo;Vernazza,Pietro;Thiel,Volker;Vidal,JorgeE;Albrich,WernerC
  • 通讯作者:
    Albrich,WernerC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian Akerley其他文献

Brian Akerley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian Akerley', 18)}}的其他基金

Mechanisms underlying adhesion and colonization in pneumococcal keratitis
肺炎球菌角膜炎粘附和定植的机制
  • 批准号:
    10727764
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury
基于 miRNA 的新型疗法的靶向递送治疗肺炎引起的急性肺损伤
  • 批准号:
    10700810
  • 财政年份:
    2022
  • 资助金额:
    $ 19.44万
  • 项目类别:
Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury
基于 miRNA 的新型疗法的靶向递送治疗肺炎引起的急性肺损伤
  • 批准号:
    10395376
  • 财政年份:
    2022
  • 资助金额:
    $ 19.44万
  • 项目类别:
Mechanisms of Haemophilus influenzae pathogenesis in the lung
流感嗜血杆菌肺部发病机制
  • 批准号:
    8416316
  • 财政年份:
    2012
  • 资助金额:
    $ 19.44万
  • 项目类别:
Mechanisms of Haemophilus influenzae pathogenesis in the lung
流感嗜血杆菌肺部发病机制
  • 批准号:
    8604132
  • 财政年份:
    2012
  • 资助金额:
    $ 19.44万
  • 项目类别:
Mechanisms of Haemophilus influenzae pathogenesis in the lung
流感嗜血杆菌肺部发病机制
  • 批准号:
    8297393
  • 财政年份:
    2012
  • 资助金额:
    $ 19.44万
  • 项目类别:
Mechanisms of Haemophilus influenzae pathogenesis in the lung
流感嗜血杆菌肺部发病机制
  • 批准号:
    8292726
  • 财政年份:
    2011
  • 资助金额:
    $ 19.44万
  • 项目类别:
Global regulatory interactions in bacterial pathogenesis
细菌发病机制中的全局调控相互作用
  • 批准号:
    7069054
  • 财政年份:
    2002
  • 资助金额:
    $ 19.44万
  • 项目类别:
Global regulatory interactions in bacterial pathogenesis
细菌发病机制中的全局调控相互作用
  • 批准号:
    6802916
  • 财政年份:
    2002
  • 资助金额:
    $ 19.44万
  • 项目类别:
Global regulatory interactions in bacterial pathogenesis
细菌发病机制中的全局调控相互作用
  • 批准号:
    6894832
  • 财政年份:
    2002
  • 资助金额:
    $ 19.44万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了